Protagonist Therapeutics, Inc.
NASDAQ:PTGX
41.49 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||
Current Assets: | ||||||||||
Cash & Cash Equivalents
| 186.727 | 125.744 | 123.665 | 117.358 | 33.006 | 82.233 | 106.029 | 21.084 | 4.055 | 9.324 |
Short Term Investments
| 154.89 | 111.611 | 203.235 | 188.451 | 100.011 | 46.62 | 37.972 | 56.515 | 7.868 | 0 |
Cash and Short Term Investments
| 341.617 | 237.355 | 326.9 | 307.809 | 133.017 | 128.853 | 155.459 | 87.749 | 11.923 | 9.324 |
Net Receivables
| 10.332 | 0.052 | 1.566 | 2.426 | 6.755 | 6.511 | 3.221 | 2.241 | 0.715 | 0.523 |
Inventory
| 0 | -0.094 | 8.503 | 3.976 | 4.795 | 2.139 | -8.746 | -7.652 | 1.263 | 0.01 |
Other Current Assets
| 3.628 | 5.67 | 12.27 | 7.371 | 5.539 | 4.063 | 5.13 | 3.404 | 1.568 | 0.056 |
Total Current Assets
| 355.577 | 237.355 | 340.736 | 315.606 | 145.311 | 137.503 | 150.947 | 83.244 | 14.206 | 9.913 |
Non-Current Assets: | ||||||||||
Property, Plant & Equipment, Net
| 2.149 | 4.626 | 6.734 | 6.412 | 7.723 | 0.861 | 0.879 | 0.562 | 0.609 | 0.415 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | -1.04 | -0.45 | -0.45 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0.225 | 0.225 | 2 | 0.45 | 0.45 | 11.458 | 10.15 | 0.03 | 0 |
Tax Assets
| 0 | 0 | 0 | 1.04 | 1.433 | 0.658 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.225 | 5.722 | 0 | 0.45 | 0.45 | 0.45 | 0.45 | 0.034 | 0 | 0 |
Total Non-Current Assets
| 2.374 | 10.573 | 6.959 | 8.862 | 9.606 | 1.969 | 12.787 | 10.746 | 0.639 | 0.415 |
Total Assets
| 357.951 | 247.928 | 347.695 | 324.468 | 154.917 | 139.472 | 163.734 | 93.99 | 14.845 | 10.328 |
Liabilities & Equity: | ||||||||||
Current Liabilities: | ||||||||||
Account Payables
| 0.772 | 3.64 | 1.6 | 3.075 | 2.79 | 5.711 | 1.257 | 1.163 | 1.247 | 0.349 |
Short Term Debt
| 2.282 | 5.03 | 4.4 | 2.918 | 2.512 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0.069 | 1.601 | 14.477 | 41.53 | 8.223 | 31.752 | 0 | 0 | 0 |
Other Current Liabilities
| 18.22 | 22.509 | 36.415 | 19.771 | 12.366 | 12.224 | 9.546 | 5.272 | 1.879 | 1.001 |
Total Current Liabilities
| 21.274 | 31.179 | 44.016 | 40.241 | 35.406 | 26.158 | 42.555 | 6.435 | 3.126 | 1.35 |
Non-Current Liabilities: | ||||||||||
Long Term Debt
| 0 | 1.141 | 3.658 | 4.5 | 15.755 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | -1.04 | 23.792 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0.221 | 0 | 0 | 1.04 | 1.269 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| -0.221 | 0 | 0 | 0.121 | 0 | 0.799 | 0.547 | 0 | 2.123 | 1.023 |
Total Non-Current Liabilities
| 0 | 784.683 | 3.658 | 4.621 | 39.547 | 0.799 | 0.547 | 0 | 2.123 | 1.023 |
Total Liabilities
| 21.274 | 784.683 | 47.674 | 44.862 | 74.953 | 26.957 | 43.102 | 6.435 | 5.249 | 2.373 |
Equity: | ||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 93.99 | 36.996 | 20.576 |
Common Stock
| 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Earnings
| -615.71 | -536.755 | -409.362 | -283.811 | -217.661 | -140.474 | -101.55 | -64.593 | -27.416 | -12.558 |
Accumulated Other Comprehensive Income/Loss
| -0.105 | -0.359 | -0.299 | 0.028 | -0.221 | -0.233 | -0.006 | -0.245 | -0.102 | -0.1 |
Other Total Stockholders Equity
| 952.491 | 752.722 | 709.682 | 563.389 | 297.846 | 253.222 | 222.188 | 58.403 | 0.118 | 0.037 |
Total Shareholders Equity
| 336.677 | -536.755 | -409.362 | -283.811 | -217.661 | -140.474 | -101.55 | -64.593 | 9.596 | 7.955 |
Total Equity
| 336.677 | -536.755 | -409.362 | -283.811 | -217.661 | -140.474 | -101.55 | -64.593 | 9.596 | 7.955 |
Total Liabilities & Shareholders Equity
| 357.951 | 247.928 | -361.688 | -238.949 | -142.708 | -113.517 | -58.448 | -58.158 | 14.845 | 10.328 |